Tumors Clinical Trials

155 clinical trials for Tumors across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors — RECRUITING
• HP Pyruvate MRI in Cancers — RECRUITING · PHASE1
• ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling — RECRUITING · PHASE2
• The Drug Rediscovery Protocol (DRUP Trial) — RECRUITING · PHASE2
• Phase 1 Study of E7090 in Subjects With Solid Tumor — COMPLETED · PHASE1
• POWER UP: Participating Online While Exercising to Recover Using Play — TERMINATED · NA
• Comparing 68Ga-CTR-FAPI and 18F-FDG PET/ CT in Cancer Detection — COMPLETED
• Perioperative Risk Study — ACTIVE_NOT_RECRUITING · NA
• CDK4/6 Tumor, Abemaciclib, Paclitaxel — COMPLETED · PHASE1
• A Study to Assess the Safety and Efficacy of ASP1650, a Monoclonal Antibody Targeting Claudin 6 (CLDN6), in Male Subjects With Incurable Platinum Refractory Germ Cell Tumors — COMPLETED · PHASE2
• A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors — COMPLETED · PHASE1
• Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction — COMPLETED · PHASE1
• A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• Cohort of Tumors With POLE/D1 Mutation — OTHER
• Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) — ACTIVE_NOT_RECRUITING · PHASE2
• Point of Care 3D Ultrasound for Various Applications: A Pilot Study — COMPLETED
• A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4 — COMPLETED · PHASE1
• A Novel 68Ga Labeled FAP Ligand PET/CT in Patients With Various Malignant Tumors — OTHER · NA
• A Trial of Lenvatinib (E7080) Plus Pembrolizumab in Participants With Selected Solid Tumors — COMPLETED · PHASE1
• A Phase I Study of PLX038 in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma — COMPLETED · PHASE1
• Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors — WITHDRAWN · PHASE1
• A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors — TERMINATED · PHASE1
• A Study of AMG 820 in Subjects With Advanced Solid Tumors — COMPLETED · PHASE1
• Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer — COMPLETED · PHASE1
• Safety Study of AMG 228 to Treat Solid Tumors — TERMINATED · PHASE1
• A Study of AMG 337 in Subjects With Advanced Solid Tumors — COMPLETED · PHASE1
• Comparison of the Cosmetic Outcome of Hypofractionated Versus Normofractionated IMRT in Treatment of Breast Cancer — COMPLETED · PHASE3
• XACT ACE Observational Registry — OTHER
• NY-ESO-1 Protein With Montanide and CpG 7909 as Cancer Vaccine in Several Tumors — COMPLETED · PHASE1
• PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer) — COMPLETED · PHASE2
• Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs — TERMINATED · PHASE1
• A Study of Vorinostat in Patients With Solid Tumors (MK-0683-029) — COMPLETED · PHASE1
• Research on the Application and Mechanism of New Biological Probes in Biomedicine — COMPLETED
• Kypho-IORT: Intraoperative Radiotherapy During Kyphoplasty for Spinal Metastases — COMPLETED · PHASE2
• NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS) — COMPLETED · PHASE1
• Optimal Application Dose of Superficial Hyperthermia — COMPLETED · PHASE3
• A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma — COMPLETED · PHASE1
• A Study of Atezolizumab in Advanced Solid Tumors — COMPLETED · PHASE2
• Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors — SUSPENDED · PHASE1
• A Phase 1b/2a Study Evaluating AMG 232 in Metastatic Melanoma — COMPLETED · PHASE1
• First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Mirvetuximab Soravtansine in Adults With Ovarian Cancer and Other Folate Receptor 1 (FOLR1)-Positive Solid Tumors — COMPLETED · PHASE1
• Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM) — COMPLETED · PHASE1
• Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer — TERMINATED · PHASE1
• Bioavailability and Food Effect Study of TKI258 (CSF Capsules vs. FMI Capsules)in Adult Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function — COMPLETED · PHASE1
• to evaluate188Re-BMEDA-liposome in Patient With Primary Solid Tumor in Advanced or Metastatic Stage — TERMINATED · PHASE1
• Comparing Magnetic Resonance Imaging/Spectroscopy Techniques — TERMINATED
• Proton Radiotherapy for Recurrent Tumors — COMPLETED · NA

Refine this search